QuidelOrtho Gets CLIA Waiver for COVID Rapid Test
QuidelOrtho, a provider of innovative in vitro diagnostic technologies designed for point-of-care...
QuidelOrtho, a provider of innovative in vitro diagnostic technologies designed for point-of-care...
The Prospective Risk Adjustment solution delivers timely, evidence-based AI-powered insights that directly impact member outcomes.
Learn about dependable noninvasive H. pylori diagnostic testing solutions, like the BreathID®...
Change is a constant, and this is reflected in the lab life cycle. The need for comprehensive, immersive digital planning is critical.
QuidelOrtho, a provider of innovative in vitro diagnostic technologies designed for point-of-care...
Learn about dependable noninvasive H. pylori diagnostic testing solutions, like the BreathID®...
Researchers from UC Santa Cruz and MIT have created a device that mimics a biological concept in order to detect disease.
Chris Wolski, CLP’s director of Business Intelligence, David West, CEO of Proscia, and Lou Welebob, vice president and general manager of pathology at Agilent, take a deep dive into the big challenges facing clinical labs today.
Wearable technology has emerged as a potential innovation in the early detection of COVID-19 among NCAA Division I female student-athletes.
T2 Biosystems, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the T2Biothreat Panel.
MagBench offers a bench-top robotic cell-free DNA (cfDNA) extraction workstation optimized for Yourgene’s Sage 32 NIPT Workflow.
Verichem offers multi-level enzyme calibration verification materials for liver function testing as part of its Enzyme ER Verifier Kit.
Cairn Diagnostics' 13C-Spirulina Gastric Emptying Breath Test was included in ACG Clinical Guidelines for the diagnosis of gastroparesis.
The LigoLab Informatics Platform is now available in a tiered pricing model that caters to various laboratory discipline types.
Myriad Genetics revealed survey results indicating widespread misconceptions about ovarian cancer screening among a majority of women.